Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney Diseases

NCT04689074 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-08-01

No results posted yet for this study

Summary

This is a prospective, clinical, multicentre study aimed to collect biological samples and study microbiota from subjects suffering from chronic kidney disease and from healthy volunteers. Microbiota is a complex consortium of microorganisms, located at the mucosal level (in particular intestinal, oral and vaginal) having a key role in human health and in the onset of several diseases. Microbiota alterations have been found in several diseases (gastrointestinal, metabolic, renal, oncological, gynaecological).

The study will allow to:

* Provide biological samples (faeces, saliva, blood, urine) from healthy volunteers and patients suffering from chronic renal diseases to the first Italian microbiota biobank;
* Study microorganisms using different in vitro and in vivo techniques;
* Study the link between the microbiota and the disease. This study is part of the BIOMIS project (Project Code: ARS01\_01220), presented as part of the "Avviso per la presentazione di progetti di ricerca industriale e sviluppo sperimentale nelle 12 aree di specializzazione individuate dal PNR 2015-2020" and admitted to funding under the National Operational Program "Ricerca e Innovazione" 2014-2020 by directorial decree of MIUR - Department for Higher Education and Research - n. 2298 of 12 September 2018. BIOMIS includes several clinical studies that enrol patients with different pathologies to collect and store biological samples and study microbiota.

Conditions

  • Autosomal Dominant Polycystic Kidney Disease (ADPKD)
  • Advanced-Chronic Kidney Disease (CKD)
  • Diabetic Kidney Disease (DKD)
  • IgA Nephropathy (IgAN)

Interventions

OTHER

Biological sample collection

Collection of faeces, urine, saliva, PBMC and blood for biobanking, to evaluate the proteomic, metascriptomic, metabolomic, metagenomic, and metagenetic profile, and to perform routine screening

OTHER

Questionnaire

Anamnestic questionnaire, 3-day food questionnaire, Food Frequency Questionnaire

OTHER

Medical examination

Blood pressure measurement, abdominal and thoracic physical examination

Sponsors & Collaborators

  • University Of Perugia

    collaborator OTHER
  • Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies

    collaborator OTHER
  • Istituti Tumori Giovanni Paolo II

    collaborator NETWORK
  • University of Salento

    collaborator OTHER
  • University of Bari Aldo Moro

    collaborator OTHER
  • Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

    lead OTHER

Principal Investigators

  • Loreto Gesualdo, MD · Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-03
Primary Completion
2022-05-10
Completion
2022-05-10

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04689074 on ClinicalTrials.gov